News & Events » Media Stories

Feb. 13, 2012 – Xconomy Detroit - RetroSense Therapeutics’ Blindness Therapy Lands Investment

Wednesday, 29 February 2012

The Foundation invests $250,000 in this optogenetics research project for retinitis pigmentosa.